Analyst Consensus ?
ConsensusHold44 ratings
Bullish1125.0%
Neutral2965.9%
Bearish49.1%
The Travelers Companies, Inc. · TRV · FY2026 Q3 · Calendar Q4 2026
Travelers posts strong Q3 underwriting results as AI investment continues
Travelers' Q3 results support a constructive operating picture: strong underwriting profitability, record investment income and continued capital return were paired with a confident outlook. The main question is whether these results remain durable as loss costs, reserves, catastrophe exposure and cyber reinsurance changes develop.
Reported Before market openNYSEFinancial Services
$80.07B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $7.39
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $11.36B
Revenue surprise
—
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+0.5%
Event window
SPY move
-1.1%
Same window
Abnormal move
+1.6%
Stock minus SPY
Volume
1.0×
Versus trailing sessions
Subsequent drift
0.0%
Up to 20 sessions
TRVSPY benchmark
Ask FN2 about TRV FY2026 Q3
Transcript, numbers and history already loaded
What drove TRV's +0.5% move after FY2026 Q3 earnings?What changed in TRV's guidance and outlook in FY2026 Q3?Give me the bull and bear case for TRV after FY2026 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, Travelers reported a lower 86.8% combined ratio but a strong 84.1% underlying combined ratio, record net investment income above $900 million, $1.8 billion of capital returned, a new digital tool for unrepresented claimants, and higher cyber quota-share ceding that reduces Q4 net written premiums by $165 million.
Guidance delta
Maintained; the supplied analysis describes management as confident in the durability of underlying underwriting income and focused on incremental growth in 2027.
Key takeaways
- Underlying underwriting profitability remained strong, with an 84.1% underlying combined ratio cited in the transcript analysis.
- Net investment income exceeded $900 million for the first time, according to the supplied analysis.
- Travelers returned $1.8 billion to shareholders while continuing investments in AI-enabled claims tools and data analytics.
- The company increased cyber reinsurance quota-share ceding effective October 1, reducing Q4 net written premiums by $165 million.
Management priorities
- Expand AI and digital claims tools to improve settlement speed and fairness.
- Continue investing in data analytics, external data and predictive modeling.
- Use cyber reinsurance, risk-control services and book-consolidation opportunities to support capital efficiency and growth.
Follow TRV with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$390.35Current
$95Low
$279.67Average
$430High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 16, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Oct 12, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Oct 9, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Oct 7, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Oct 7, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Sep 21, 2026 |
| Roth Capital | Buy | Buy | Maintain | Jul 21, 2026 |
| Morgan Stanley | Underweight | Underweight | Maintain | Jul 21, 2026 |
| BMO Capital | Market Perform | Outperform | Downgrade | Jul 21, 2026 |
| Barclays | Underweight | Underweight | Maintain | Jul 21, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jul 20, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Jul 20, 2026 |
| B of A Securities | Underperform | Underperform | Maintain | Jul 20, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jul 15, 2026 |
| TD Cowen | Sell | Hold | Downgrade | Jul 13, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 8, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Outperform | Downgrade | Jul 8, 2026 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Jul 6, 2026 |
| HSBC | Hold | Hold | Maintain | Jul 6, 2026 |
| Jefferies | Hold | Hold | Maintain | Apr 11, 2025 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jan 23, 2025 |
| Goldman Sachs | Buy | Sell | Upgrade | Jan 8, 2025 |
| Janney Montgomery Scott | Neutral | Buy | Downgrade | Nov 21, 2024 |
| Roth MKM | Buy | Buy | Maintain | Oct 21, 2024 |
| Deutsche Bank | Hold | Hold | Maintain | Aug 7, 2024 |
| William Blair | Market Perform | Outperform | Downgrade | Jun 28, 2024 |
| Oppenheimer | Perform | Perform | Maintain | Apr 5, 2024 |
| CFRA | Buy | Hold | Upgrade | Apr 19, 2023 |
| MKM Partners | Buy | Buy | Maintain | Jan 25, 2023 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jun 23, 2022 |
| Credit Suisse | Neutral | Neutral | Maintain | Apr 1, 2021 |
| Buckingham Research | Neutral | Neutral | Maintain | Jan 22, 2020 |
| Buckingham | Neutral | Neutral | Maintain | Jan 22, 2020 |
| Bank of America | Neutral | Buy | Downgrade | Sep 18, 2019 |
| Keefe Bruyette & Woods | Market Perform | Outperform | Downgrade | Jun 6, 2019 |
| B. Riley Securities | Neutral | Neutral | Maintain | Aug 7, 2018 |
| B. Riley FBR | Neutral | Neutral | Maintain | Aug 7, 2018 |
| Argus | Hold | Buy | Downgrade | May 5, 2018 |
| Argus Research | Buy | Buy | Maintain | Apr 26, 2018 |
| Atlantic Equities | Neutral | Underweight | Upgrade | Jan 26, 2018 |
| FBR Capital | Market Perform | Outperform | Downgrade | Feb 13, 2017 |
| Sandler O'Neill | Hold | Buy | Downgrade | Jul 28, 2014 |
| Guggenheim | Buy | Neutral | Upgrade | May 12, 2014 |
| Drexel Hamilton | Hold | Buy | Downgrade | Apr 24, 2013 |
| Sterne Agee | Neutral | Neutral | Maintain | Apr 20, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $390.35. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Cantor Fitzgerald | Analyst unavailable | $378 | $360.64 | -3.2% | Oct 7, 2026 |
| BMO Capital | Analyst unavailable | $379 | $368.5 | -2.9% | Jul 21, 2026 |
| Goldman Sachs | Alex Scott | $350 | $368.66 | -10.3% | Jul 20, 2026 |
| Truist Financial | Mark Hughes | $425 | $366.87 | +8.9% | Jul 20, 2026 |
| Raymond James | Gregory Peters | $430 | $368.98 | +10.2% | Jul 20, 2026 |
| Raymond James | Analyst unavailable | $307 | $368.98 | -21.4% | Jul 20, 2026 |
| Morgan Stanley | Analyst unavailable | $290 | $336.83 | -25.7% | Jul 15, 2026 |
| Piper Sandler | Paul Newsome | $340 | $339.42 | -12.9% | Jul 13, 2026 |
| Truist Financial | Mark Hughes | $395 | $337.48 | +1.2% | Jul 10, 2026 |
| Evercore ISI | Analyst unavailable | $329 | $337.48 | -15.7% | Jul 10, 2026 |
| Barclays | Alex Scott | $295 | $303.9 | -24.4% | Jun 12, 2026 |
| Seaport Global | Analyst unavailable | $322 | $306.46 | -17.5% | May 26, 2026 |
| BMO Capital | Analyst unavailable | $314 | $305.76 | -19.6% | Apr 20, 2026 |
| Goldman Sachs | Robert Cox | $304 | $283.19 | -22.1% | Jan 7, 2026 |
| Evercore ISI | Analyst unavailable | $317 | $284.98 | -18.8% | Jan 7, 2026 |
| Mizuho Securities | Yaron Kinar | $317 | $290.64 | -18.8% | Dec 15, 2025 |
| Barclays | Analyst unavailable | $313 | $284.97 | -19.8% | Oct 8, 2025 |
| Wells Fargo | Elyse Greenspan | $264 | $255.99 | -32.4% | Jul 10, 2025 |
| Morgan Stanley | Bob Huang | $269 | $274.54 | -31.1% | May 19, 2025 |
| Piper Sandler | Paul Newsome | $310 | $241.51 | -20.6% | Jan 24, 2025 |
| BMO Capital | Michael Zaremski | $270 | $259.7 | -30.8% | Oct 22, 2024 |
| JMP Securities | Meyer Shields | $273 | $259.7 | -30.1% | Oct 21, 2024 |
| Roth Capital | Harry Fong | $300 | $265.45 | -23.1% | Oct 21, 2024 |
| Wells Fargo | Elyse Greenspan | $256 | $265.45 | -34.4% | Oct 21, 2024 |
| Deutsche Bank | Cave Montazeri | $277 | $264.82 | -29.0% | Oct 18, 2024 |
| RBC Capital | Mark Dwelle | $273 | $264.82 | -30.1% | Oct 18, 2024 |
| Barclays | Alex Scott | $286 | $231.42 | -26.7% | Sep 4, 2024 |
| Piper Sandler | Paul Newsome | $207 | $203.48 | -47.0% | Jul 22, 2024 |
| Goldman Sachs | Alex Scott | $196 | $203.48 | -49.8% | Jul 22, 2024 |
| CFRA | Cathy Seifert | $225 | $203.48 | -42.4% | Jul 19, 2024 |
| Evercore ISI | David Motemaden | $236 | $203.48 | -39.5% | Jul 19, 2024 |
| Morgan Stanley | Bob Huang | $210 | $203.48 | -46.2% | Jul 19, 2024 |
| BMO Capital | Michael Zaremski | $240 | $203.48 | -38.5% | Jul 19, 2024 |
| J.P. Morgan | Jimmy Bhullar | $242 | $220.6 | -38.0% | Jul 19, 2024 |
| J.P. Morgan | Stephen Tusa | $95 | $213.07 | -75.7% | Jul 15, 2024 |
| RBC Capital | Mark Dwelle | $225 | $206.58 | -42.4% | Apr 18, 2024 |
| Goldman Sachs | Alex Scott | $202 | $206.58 | -48.3% | Apr 17, 2024 |
| CFRA | Cathy Seifert | $235 | $205.25 | -39.8% | Apr 17, 2024 |
| Morgan Stanley | Bob Huang | $214 | $206.06 | -45.2% | Apr 17, 2024 |
| UBS | Brian Meredith | $225 | $223.12 | -42.4% | Apr 17, 2024 |
| Raymond James | Gregory Peters | $185 | $159.68 | -52.6% | Jul 25, 2022 |
| RBC Capital | Mark Dwelle | $165 | $156.83 | -57.7% | Jul 22, 2022 |
| Wolfe Research | Charles Lederer | $156 | $163.15 | -60.0% | Jun 22, 2022 |
| Morgan Stanley | Analyst unavailable | $184 | $176.88 | -52.9% | Apr 20, 2022 |
| RBC Capital | Mark Dwelle | $190 | $184.86 | -51.3% | Apr 9, 2022 |
| Credit Suisse | Andrew Kligerman | $178 | $166.82 | -54.4% | Jan 30, 2022 |
| Jefferies | Yaron Kinar | $176 | $161.48 | -54.9% | Jan 6, 2022 |
| Bank of America Securities | Joshua Shanker | $152 | $156.96 | -61.1% | Oct 20, 2021 |
| UBS | Brian Meredith | $158 | $154.52 | -59.5% | Oct 11, 2021 |
Track every rating change on TRV the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationThe Travelers Companies, Inc., through its network of subsidiaries, delivers a broad spectrum of commercial and personal property and casualty insurance products and services. These offerings cater to businesses, government entities, associations, and individual clients both within the United States and internationally. The company's operations are divided into three primary segments: Business Insurance, Bond & Specialty Insurance, and Personal Insurance. The Business Insurance segment provides a comprehensive portfolio of commercial coverages, ranging from foundational offerings like workers' compensation, commercial auto, property, general liability, multi-peril, and employers' liability, to more specialized policies. These specialized offerings include public and product liability, professional indemnity, marine, aviation, onshore and offshore energy, construction, terrorism, personal accident, and even kidnap and ransom insurance.…
Historical context
All TRV earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| MTB-PJ M&T Bank Corporation | FY2026 Q3 · Calendar Q4 2026 | — | — | M&T Bank highlights deposits, CRE growth and AI efficiency in Q3 |
| RF-PE Regions Financial Corporation | FY2026 Q3 · Calendar Q4 2026 | — | — | Regions Financial: Fee Growth and Technology Investment Lead Q3 Readout |
| MTB-PH M&T Bank Corporation | FY2026 Q3 · Calendar Q4 2026 | — | — | M&T: Loan and Deposit Growth Offset a Modest Q3 Earnings Decline |
| RF-PC Regions Financial Corporation | FY2026 Q3 · Calendar Q4 2026 | — | — | Regions Financial Maintains Growth Outlook as Fee Revenue Sets Records |
| TFC-PI Truist Financial Corporation | FY2026 Q3 · Calendar Q4 2026 | — | — | Truist refocuses on relationship banking while investing for growth |
| RF Regions Financial Corporation | FY2026 Q3 · Calendar Q4 2026 | — | -0.1% | Regions maintains guidance as fee revenue and capital stay strong |
Latest beats and misses
Who reports nextBeat on EPS
- AAFY2026 Q3 · October 15, 2026+20.5% EPS+7.2% move
- JBHTFY2026 Q3 · October 15, 2026+0.6% EPS-2.0% move
- PLDFY2026 Q3 · October 15, 2026+105.9% EPS-2.7% move
- BNYFY2026 Q3 · October 15, 2026+4.4% EPS+3.2% move
- USB-PRFY2026 Q3 · October 15, 2026+1.5% EPS— move
- USB-PSFY2026 Q3 · October 15, 2026+1.5% EPS— move
Get the TRV recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-10-16T16:03:11.697757+00:00
- FN2 earnings calendar · 2026-10-16T01:23:22.079841+00:00
- Polygon adjusted daily market bars · 2026-10-16T17:40:40.928583+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-16T17:40:40.925878+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-16. For educational purposes only; not investment advice.